Schneiderman Prelims Vol-I. qxd

INFLAMMATORY DISEASES
Crohn’s disease, metastatic – granulomatous ulcer 
JAAD
41:476–479, 1999; JAAD 28:115–117, 1993
Erythema multiforme 
BJD 148:388–401, 2003
Fibrosis from longstanding edema – ischemic ulcers 
Rook
p.2264, 1998, Sixth Edition
Hidradenitis suppurativa
Pancreatic panniculitis (fat necrosis) 
Panniculitis, including Weber–Christian disease, lupus
profundus, 
α
1
-antitrypsin deficiency 
AD 123:1655–1661, 1987
Pyoderma gangrenosum 
Dermatology 195:50–51, 1997; J
Derm Surg Oncol 20:833–836, 1994; JAAD 18:559–568, 1988;
pyoderma gangrenosum with C7 deficiency 
JAAD 27:356–359,
1992; AD 22:655–680, 1930; bullous pyoderma gangrenosum
Sarcoid – ulcerative sarcoid – tender, ‘punched out’, and often
bilateral 
JAAD 53:917, 2005; AD 133:215–219, 1997; AD
123:1531–1534, 1987; AD 118:9331–933, 1982
METABOLIC
Acrodermatitis enteropathica – foot ulcers
Antiphospholipid deficiency 
BJD 148:388–401, 2003
Antithrombin III deficiency 
BJD 148:388–401, 2003
C3 deficiency 
BJD 148:388–401, 2003
Calcinosis – calcinosis cutis; calcinosis of muscles or
subcutaneous tissue – overlying ulceration 
Rook p.2267, 1998,
Sixth Edition
Calciphylaxis (vascular calcification cutaneous necrosis
syndrome) 
AD 140:1045–1048, 2004; BJD 143:1087–1090,
2000; JAAD 40:979–987, 1999; JAAD 33:53–58, 1995;
JAAD 33:954–962, 1995
Cold agglutinins 
BJD 148:388–401, 2003
Cryofibrinogenemia 
Am J Med 116:332–337, 2004
Cryoglobulinemia – type I 
NEJM 347:1412–1418, 2002; mixed –
bilateral in 87% of patients 
AD 139:391–393, 2003; hemorrhagic
crusted leg ulcer 
Cutis 70:319–323, 2002
Defective organization of the extracellular matrix of fibronectin
BJD 142:166–170, 2000
Defective fibrinolysis 
BJD 148:388–401, 2003
Diabetes mellitus 
Diabet Med 16:889–909, 1999; Diabetes
40:1305–1313, 1991; necrobiosis lipoidica diabeticorum,
ulcerative 
Rook p.2267, 1998, Sixth Edition; neuropathic and
large vessel and microvascular foot ulcers (mal perforans) 
Factor V Leiden deficiency 
BJD 148:388–401, 2003; factor V
Leiden mutation and cryofibrinogenemia 
JAAD 51:S122–124,
2004; heterozygous factor V Leiden deficiency
BJD 143:1302–1305, 2000
Factor XIII deficiency 
BJD 148:388–401, 2003
Gamma heavy chain disease
Gaucher’s disease
Gout – subcutaneous tophus 
AD 134:499–504, 1998
Am J Pathol 32:871–895, 1956
Hematologic disease
Dysproteinemias – cryoglobulinemia, cold agglutinins, 
macroglobulinemia, cryofibrinogenemia, myeloma, polyclonal
dysproteinemia 
BJD 148:388–401, 2003
Red blood cell disorders – sickle cell disease, hereditary
spherocytosis 
Ped Derm 20:427–428, 2003; Clin Exp
Dermatol 16:28–30, 1991; in atypical locations (backs of feet)
Dermatologica 181:56–59, 1990; thalassemia, polycythemia
vera, G-6PD deficiency, hereditary elliptocytosis, hereditary
non-spherocytichemolytic anemia 
BJD 148:388–401, 2003
White blood cell disease – leukemia, granulocytopenia 
BJD
148:388–401, 2003
Platelet disorders – essential thrombocythemia
Hautarzt 35:259–262, 1984; Br J Surg 60 (5):377–380,
1973; thrombotic thrombocytopenic purpura BJD
148:388–401, 2003
Felty’s syndrome 
BJD 148:388–401, 2003; Ghatan p.74,
2002, Second Edition
Thrombotic angiopathy
Edema due to cardiac or renal failure
Extramedullary hematopoiesis 
JAAD 4:592–596, 1981
Gamma heavy chain disease
Gout 
BJD 148:388–401, 2003
Homocysteinemia 
Ned Tijdschr Geneeskd 142:2706–2707,
1998 (Dutch) 
Hyperoxaluria – livedo reticularis, ulcers, and peripheral
gangrene 
JAAD 49:725–728, 2003; AD 136:1272–1274, 2000
Hyperparathyroidism 
BJD 83:263–268, 1970
Hyperviscosity – paraproteinemia, leukemia 
BJD 148:388–401,
2003
Malnutrition
Myxedema 
BJD 148:388–401, 2003
Necrobiosis lipoidica diabeticorum 
JAAD 17:351–354, 1987